Shojaei Amir sold $450K of HROW
Shojaei Amir (CHIEF SCIENTIFIC OFFICER) sold 11,250 shares of HARROW, INC. (HROW) at $40.00 ($0.45M total) on 2026-08-14.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the open-market sale of 11,250 shares for about $450,000, with holdings after the transaction reported as 0 shares.
Market read
Traders may note insider selling, but the disclosure does not include guidance, clinical, regulatory, or deal information.
What to watch
The filing states no pre-arranged 10b5-1 plan, but that alone does not establish intent or future trading restrictions.
Background
This is an SEC Form 4 insider transaction for Harrow, Inc. (HROW) by its Chief Scientific Officer.
Ticker impact
SEC Form 4 shows Chief Scientific Officer Shojaei Amir sold 11,250 shares of Harrow at $40.00 on 2026-08-14.
Likely minimal near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by other disclosures.
Form 4 insider sales are common and, absent additional context like material adverse events or guidance changes, usually have limited predictive value for price.
Market effects
No clear sector read-through from a single insider sale disclosure.
None indicated.
None indicated.
Counterpoint
The sale could be unrelated to company outlook (tax, diversification, personal liquidity), so it may not signal bearish fundamentals.
Key entities
- issuerHarrow, Inc.
Company whose insider transaction is disclosed on Form 4.
- insiderShojaei Amir
Chief Scientific Officer who sold shares.
